Anbio Biotechnology NNNN
NASDAQ NNNN
$6.54 -0.06 (-0.91%)
At close: Sep 4, 2026 · 4:00 PM EDT

Anbio Biotechnology (NNNN) Price to Book (2025)

Anbio Biotechnology (NNNN) posted Price to Book of 143.49 for Q4 2025, down 12.25% on a QoQ basis from 163.52 in Q2 2025.

Analysis

Anbio Biotechnology (NNNN) Price to Book (2025) Analysis & Trends

Anbio Biotechnology has reported Price to Book for 1 years, with the latest figure at 143.49 in Q4 2025.

  • On a quarterly basis, Price to Book changed N/A year-over-year to 143.49 in Q4 2025; TTM through Dec 2025 was 143.49, a N/A change from a year earlier, with the FY2025 full-year figure at 143.49, changed N/A from the prior year.
  • Price to Book was 143.49 for Q4 2025 at Anbio Biotechnology, down from 163.52 in the prior quarter.
  • The five-year high for Price to Book was 163.52 in Q2 2025, with the low at 143.49 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 31.10 Bn 29.22 Bn 2.18 Bn
2 Lantheus Holdings 6.59 Bn 6.00 Bn 241.86 Mn
3 Heartflow 4.24 Bn 3.87 Bn 53.19 Mn
4 Neogen 2.58 Bn 2.39 Bn 107.80 Mn
5 Butterfly Network 1.75 Bn 1.62 Bn 23.29 Mn
6 QuidelOrtho 954.15 Mn 830.75 Mn -
7 Ceribell 944.88 Mn 815.62 Mn 25.94 Mn
8 Anbio Biotechnology 941.05 Mn 929.15 Mn -
9 Varex Imaging 780.16 Mn 694.86 Mn 76.70 Mn
10 Prenetics Global 357.49 Mn 298.35 Mn 30.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 143.49
Jun 30, 2025 163.52